Drug Enforcement D-830-2013

Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.

Status

Terminated

Classification

Class II

Report Date

August 7, 2013

Termination Date

January 31, 2014

Product Information

Product description
Olanzapine Tablets, USP, 10 mg, Rx Only, 30 tablets per bottle, Mfd for: Prasco Laboratories, Mason OH, 45040, USA, Mfd by: Torrent Pharmaceuticals Ltd., Indrad-382 721, Dist. Mehsana India, NDC 66993-463-30
Product quantity
18,721 bottles
Reason for recall
Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Torrent Pharma Inc
Address
5380 Holiday Ter Ste 40, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-830-2013
Event ID
65780
Recall initiation date
July 22, 2013
Center classification date
August 1, 2013
Code info
Lot #: BS392004A, Exp: 09/2014
More code info